The human protein kinase X (PRKX) gene was identified previously as a cAMP-dependent serine/threonine kinase that is aberrantly expressed in autosomal dominant polycystic disease kidneys and normally expressed in fetal kidneys. The PRKX kinase belongs to a serine/threonine kinase family that is phylogenetically and functionally distinct from classical protein kinase A kinases. Expression of PRKX activates cAMP-dependent renal epithelial cell migration and tubular morphogenesis in cell culture, suggesting that it might regulate branching growth of the collecting duct system in the fetal kidney. With the use of a mouse embryonic kidney organ culture system that recapitulates early kidney development in vitro, it is demonstrated that lentiviral vector-driven expression of a constitutively active, cAMP-independent PRKX in the ureteric bud epithelium stimulates branching morphogenesis and results in a 2.5-fold increase in glomerular number. These results suggest that PRKX stimulates epithelial branching morphogenesis by activating cell migration and support a role for this kinase in the regulation of nephrogenesis and of collecting system development in the fetal kidney.
M
ammalian kidney development requires a complex series of inductive and morphogenetic events to produce normal branching growth of the ureteric bud to give rise to the collecting duct system and induction of mesenchymal to epithelial cell conversion and tubulogenesis to give rise to nephrons. Developmental disruption of these events cause congenital renal malformations and can lead to adult kidney disease. Targeted gene disruption and tissue culture experiments have provided information about the molecular signaling mechanisms underlying the reciprocal inductive tissue interactions that are essential for kidney development and suggest that epithelial tubular morphogenesis depends largely on the directional outgrowth of cells that are controlled by glial-derived neurotrophic factor (1); bone morphogenetic proteins (BMP), including BMP2 and BMP7 (2) ; and other signaling molecules that activate receptor tyrosine kinase receptors, including fibroblast growth factor, hepatocyte growth factor (3), and epidermal growth factor (4) . With the use of both cell culture model systems and metanephric organ culture, BMP regulation of epithelial branching morphogenesis has been shown to depend, at least in part, on functionally defined cAMP-dependent protein kinases (2, 5) .
As well as soluble growth factors, insoluble matrix factor interactions play important roles in metanephric morphogenesis. Recent studies have demonstrated that the PKD1-encoded protein polycystin-1 plays an essential role in the regulation of tubulogenesis in kidney development (6) , even though symptomatic disease most commonly presents during adult life. PKD1 gene mutations are responsible for 85% of cases of autosomal dominant polycystic kidney disease (ADPKD) and result in progressive cystic dilation of all nephron segments, which often leads to ESRD. Polycystin-1 forms multiprotein complexes with proteins of the focal adhesion plaque at the basal cell-matrix interface in the fetal kidney, with the cell-cell adherens complex at cell-cell junctions in adult kidney, and with protein complexes that are found in the primary cilium at the apical-lumen interface (7) (8) (9) (10) . Recent studies suggest that polycystin complexes may act as mechanosensors receiving signals from the extracellular matrix (via focal adhesions), adjacent cells (via cell junctions), and the tubule lumen (via cilia) followed by transduction into intracellular responses. Polycystin-1 signaling is thought to exert regulatory control of gene transcription via its translocated C-terminal tail and likely modulates cellular adhesion and migration in a way that is essential to the control epithelial cell shape, tubular diameter, and volume during kidney development (11) (12) (13) (14) .
In studies that were designed to elucidate protein kinase genes that are aberrantly activated in ADPKD and associated regulation of tubular morphogenesis in the developing kidney, the PRKX gene (15,16) was identified. The PRKX kinase belongs to a subfamily of serine/threonine kinases that are implicated in the regulation of cellular migration and morphogenesis (17) and other developmental processes, including control of granulocyte/macrophage differentiation (18, 19) . The PRKX gene encodes a cAMP-dependent kinase, is expressed in fetal and ADPKD kidneys, but is transcriptionally silent in the adult kidney (15, 17) . In situ hybridization analyses of normal fetal kidneys showed that PRKX mRNA expression was restricted to the fetal ureteric bud epithelium (17) . Expression of the PRKX kinase markedly activates cAMP-dependent migration of cultured renal epithelial cells and induces branching morphogenesis of MDCK cells in collagen gels even in the absence of hepatocyte growth factor or other stimulatory factors, an effect not produced by expression of the protein kinase A ␣ (PKA␣) kinase (17) . Taken together with the ureteric bud localization of PRKX in fetal kidneys, these observations suggested a role for PRKX in the regulation of epithelial morphogenesis during mammalian kidney development. These studies also emphasized the importance of distinguishing PRKX from PKA kinases when seeking to identify cAMP-dependent kinase genes that modulate BMP or Hedgehog-dependent responses on branching morphogenesis of the ureteric bud.
In studies reported here, we show that PRKX mRNA is broadly expressed in mesoderm-derived tissues in the fetus and that expression of PRKX stimulates the migration of human fetal collecting tubule (HFCT) epithelia in culture. Using an embryonic kidney organ culture system that recapitulates early kidney development in vitro and a newly developed technique for viral vector gene transduction by microinjection into ureteric bud epithelial cells, we demonstrate that PRKX kinase expression stimulates two distinct aspects of renal development: Ureteric bud branching and induction of glomeruli. These results suggest that PRKX might play an important role of these processes during normal kidney development and that persistent activation of this kinase may have important effects on the abnormal cystic tubular phenotype found in ADPKD.
Materials and Methods

Construction of PRKX Expression Vectors
The generation of the recombinant peGFP/PRKX, pFLAG/PRKX, and the kinase dead pFLAG/PRKX/K78R fusion protein constructs has been described previously (17) . The kinase dead GFP fusion protein encoding construct peGFP/PRKX/K78R was derived by point mutagenesis of peGFP/PRKX. The constitutively active PRKX kinase construct peGFP/PRKX.ca was engineered by point mutagenesis (His 93 changed to Gln, and Trp 202 changed to Arg) as described for PKA kinase (20) . PRKX viral-expressing constructs were generated using the VVC self-inactivating lentiviral vector. The VVC lentivector was derived from the substitution of the U3 region of the 5Ј LTR of the pHR/CMV vector (21) with the human early cytomegalovirus promoter. PRKX transgenes were expressed by cloning into the polylinker downstream of an internal constitutively active CMV promoter. The functionalities and titers of the PRKX viral constructs were tested on cultured HeLa-Tat cells. Infectious viral supernatants with a titer of Ͼ1 ϫ 10 7 transducing units (TU)/ml were produced by transient transfection of 293T cells using Lipofectamine 2000 (Invitrogen, San Diego, CA) with 8 g of VVC-peGFP/PRKX, VVC-pFLAG/PRKX/K78R, or VVC-peGFP/PRKX.ca co-transfected with 5.0 g of the pCMV⌬R8.2 plasmid producing the viral proteins, and 2.5 g of the pMD.G plasmid expressing the pseudotyping VSV glycoprotein (VSVG) (22) . After 24 h, the medium was replaced with complete medium supplemented with 4 mM sodium butyrate, and supernatants were collected 48 h later. The titer (TU/ml) was determined 48 h after infection of 3 ϫ 10 4 HeLa-Tat cells/well in 24-well plates by scoring the number of eGFP expressing cells using ultraviolet microscopy.
Northern Blot Analysis
Total RNA was fractionated on agarose/formaldehyde gels, and the integrity of RNA was monitored with ethidium bromide. RNA then was transferred to GeneScreen membranes using 25 mM sodium phosphate (pH 6.5) and mRNA sized by comparison with 28S and 18S rRNA. The filters were prehybridized overnight at 42°C in 50% formamide, 0.04% polyvinlypyrrolidone (PVP), 0.04% BSA, 0.04% Ficoll, 1% SDS, 0.75 M NaCl, 0.075 M sodium citrate, and denatured salmon sperm DNA (100 mg/ml). Hybridization with PRKX and 14S RNA 32 P-labeled cDNA probes was carried out in 0.02% PVP, 0.02% BSA, and 0.02% Ficoll at 42°C for 24 h followed by 4ϫ stringent washes of SSC ϩ 0.1% SDS at 65°C. The RNA bands were visualized by autoradiography.
In Situ Hybridization
Deparaffinized, dehydrated human kidney sections were treated with proteinase K, prehybridized with triethanolamine/acetic anhydride, and hybridized overnight with digoxigenin-substituted PRKX antisense or sense 220-bp PRKX PCR fragments as probes. 
Cell Culture
Human renal epithelial cells that were derived from normal human fetal collecting tubule epithelia were grown according to standard protocols devised in our laboratory (23, 24) . Briefly, microdissected human fetal (19 wk) collecting tubules (HFCT) were conditionally immortalized using a temperature-sensitive T antigen expressing retroviral vector (25) and clonal cells lines derived by limiting dilution. For studies described here, the HFCT clone 7F was grown to 70% confluence at 33°C then transferred to the nonpermissive temperature of 37°C for 7 to 10 d before use in adhesion and migration assays.
Migration Assay
HFCT cells were transfected with peGFP/PRKX.ca or with peGFP/ PRKX/K78R with Lipofectamine 2000 (Invitrogen), washed, and cultured for 24 h before FACS sorting to isolate GFP-positive cells. GFPpositive cells from each transfection or control nontransfected cells were washed with serum-free medium and then labeled with the fluorescence probe calcein AM (Molecular Probes, Eugene, OR). Two thousand labeled cells from each group then were suspended in 0.3 ml of DMEM plus 1% FBS and plated onto transwells with 8-M pores. The lower well contained 0.8 ml of DMEM plus 1% FBS. After 4 h, the transwells were transferred to new wells that contained 15% FBS to establish a serum gradient. The number of labeled cells that migrated through the pore to the lower chamber was measured by the appearance of fluorescence at 1, 2, 4, 6, 8, 16, 20, and 24 h after treatment using an HTS 7000 microfluorimeter (Perkin Elmer Cetus, Wellesley, MA).
Mouse Embryonic Kidney Organ Culture and Viral Vector Microinjection
Embryonic day (E) 11 to 12 kidneys were retrieved from timed pregnant CD-1 mice (Charles Rivers Laboratories, Wilmington, MA), and paired kidneys were harvested by microdissection using a dissecting stereomicroscope (Olympus, Japan). Kidneys were placed on uncoated 24-mm Transwell Clear membrane inserts, 0.4 mm pore size, in a six-well cluster (Corning Inc., Corning, NY), and 1 ml of supplemented serum-free organ culture medium that contained 50% DMEM, 50% Ham F12, 15 mM HEPES and l-glutamine (Cellgro; Mediatech, Herndon, VA), 4.5 g/L glucose, 45 mM sodium bicarbonate, 1ϫ Insulin/Transferrin/Selenium (Sigma, St. Louis, MO), 2 ϫ 10 Ϫ9 M T3, and 7 ϫ 10 Ϫ8 M prostaglandin E1 was added to the lower chamber of each well. Plates were placed into a tissue culture incubator (5% CO 2 ) for 3 to 5 d with daily media changes. For the microinjection of the VVC vector into the ureteric bud lumen, sterile transfer tips with a 15-m internal diameter (ES; Eppendorf, Hamburg, Germany) were used. On day 0, an Eppendorf Micromanipulator 5171 and transjector 5246 were used to inject 20 to 200 nl of the VSVG pseudotyped packaged VVC PRKX lentiviral stocks (titers ranged from 1 to 4 ϫ 10 7 TU/ml), VVC vector alone, or PBS control (sham) into the ureteric bud of day 11 to 12 embryonic mouse kidneys, and comparisons were made with untreated kidneys. Kidneys were cultured for 3 to 5 d after microinjection and GFP fluorescence observed daily by ultraviolet microscopy to confirm ureteric bud expression. Cultured kidneys were also fixed in 95% cold methanol for 15 min at 4°C followed by a 2-h incubation at 37°C using a mouse monoclonal anti-calbindin antibody (1:500 dilution, Sigma clone D28K), a rabbit anti-WT-1 antibody (1:100 dilution, C19 antibody; Santa Cruz Biotechnology, Santa Cruz, CA), or a rabbit anti-GFP antibody (1:250; Molecular Probes) in PBS plus 5% FBS. After two rinses in PBS-Tween and one in PBS for 10 min, the secondary antibodies donkey anti-mouse-Alexa488 or donkey anti-rabbit-Alexa 568 (Molecular Probes) were used at 1:250 dilution and incubation was carried out for 2 h at 37°C. After three washes in PBS, some kidneys were subjected to Tyramide amplification (anti-rabbit Tyramide amplification kit, 1:100; Molecular Probes) according to the manufacturer's instructions for 15 min at room temperature, washed three times in PBS, and then stored in the dark until examination by confocal microscopy.
Microscopy and Morphometric Data Analysis
Morphologic changes were documented daily using an Olympus dissecting microscope equipped with Scion computer imaging system.
Immunofluorescence analysis was carried out using a multi-photon laser scanning microscope with inverted configuration using immersion lenses (BioRad Radiance 2000, MSSM core facilities). Single images were taken of whole-kidney preparations, or stacks of multiple images were compressed for Image J analysis (National Institutes of Health, Bethesda, MD), an open domain Java image processing system that was used to calculate area and pixel value statistics, to measure distances and volumes and to create skeletonized images.
Results
Developmental Regulation of PRKX mRNA Expression in Kidney and Other Organs
Northern blot analysis of PRKX gene expression demonstrated the presence of the 6-kb PRKX mRNA in human fetal muscle, heart, brain, lung, liver, and kidney ( Figure 1A ), but no PRKX mRNA was detected in the same organs of human adult (data not shown). The expression of PRKX mRNA in human fetal kidneys was detected from 12 to 24 wk of gestation with an apparent peak in PRKX mRNA abundance at 16.5 wk (Figure 1B) . As previously reported, no PRKX gene expression was found in the adult kidney (17) . Immunohistochemical analysis showed low levels of expression in the collecting duct epithelia of 32-wk fetal kidneys and no expression in 4-or 16-yr-old human kidney sections (data not shown).
PRKX Is Expressed throughout the Fetal Kidney Ureteric Bud to the Branching Tips
In situ hybridization using the digoxigenin-substituted 220-bp PRKX PCR fragment as probe (Figure 2A through D) showed that PRKX mRNA transcripts were specifically local- ized throughout the ureteric bud epithelial cells of 14-to 17-wk human fetal kidneys from the medullary truncal regions through to the cortical branching tips, which also expressed the characteristic ureteric bud epithelial markers cytokeratin ( Figure 2E ) and polycystin-1 ( Figure 2F ) (24, 25) . PRKX mRNA and protein are also highly expressed in primary and differentiated conditionally immortalized human renal HFCT epithelial cell lines derived from microdissected fetal kidneys (Figure 3, A and B) .
PRKX Stimulates Migration of HFCT Epithelia
In previously published studies (17), we showed that PRKX but not PKA␣ activated epithelial cell migration only when cells were treated with 8-bromo-cAMP. To determine whether this stimulation of cell migration depended only on activation of the PRKX kinase, we generated a constitutively active form of PRKX by mutagenesis of amino acid residues required for binding the regulator subunit I regulator subunit (see Materials and Methods). In contrast to the cytoplasmic localization of wild-type PRKX in the absence of 8-bromo-cAMP cell treatment (17), we found that the constitutively active PRKX mutant showed predominantly nuclear localization in transfected LLC-PK1 epithelial cells (data not shown), consistent with a loss of regulator subunit I subunit binding. Furthermore, we found that constitutively active PRKX had significantly increased kinase activity in cell lysates that were prepared from transfected cells (312 Ϯ 25.9 pmol of 32 was measured at different time points for 24 h. Under the basal conditions of this assay, 2.5% of HFCT cells are migratory. A significant increase in cell migration was seen in GFP-positive cells that were transfected with the constitutively active peGFP/PRKX.ca construct after 6 h and was maintained for 24 h ( Figure 3C ). By contrast, no significant increase in migration was seen in untransfected cells or in GFP-positive cells that were transfected with the kinase-dead PRKX mutant construct peGFP/PRKX/K78R.
Expression of PRKX Kinase Activates Branching Morphogenesis and Nephron Formation in Cultured Metanephric Kidneys
Because our previous studies had shown that PRKX mRNA was expressed in the ureteric bud of human fetal kidneys, proviral supernatants were introduced into the ureteric bud lumen of E11 mouse kidneys by microinjection of VVC-peGFP/ PRKX.ca provirus encoding a constitutively active PRKX kinase and cultured for 3 d ( Figure 4A ). After 3 d in culture, GFP fluorescence analysis showed that the peGFP/PRKX fusion protein was expressed throughout the ureteric bud-derived collecting system as far as the extreme tips ( Figure 4B ). This peGFP/PRKX expression was detectable from day 2 after injection (data not shown). It is interesting that expression was seen not only in the cytoplasm of all cells but also in the nuclei of some cells at the extreme tips of the transduced ureteric bud ( Figure 4C) . No fluorescence was seen in kidneys that were injected with empty VVC vector alone ( Figure 4D ). Paired kidneys from E11 mice were injected with constitutively active PRKX expressing lentiviral vector VVC-peGFP/PRKX.ca or the empty viral vector alone (control) and cultured for 3 d. When compared with the control kidneys that were injected with the empty viral vector, kidneys that expressed the constitutively active form of PRKX had increased numbers of induced glomeruli as determined by WT-1 staining ( Figure 5, A versus B) . Quantitative analysis using IMAGE J software further showed that the constitutively active PRKX stimulated the induction of glomeruli by Ͼ2.5-fold compared with the control group (18.2 Ϯ 4.32 [PRKX] versus 6.8 Ϯ 1.9 [control]; P ϭ 0.042; Figure  5C ). By contrast, when kinase dead PRKX was injected into the ureteric bud, no significant change in glomerular induction was seen, although a trend to decrease was noted ( Figure 5 , D versus E, and F).
The effect of expression of PRKX on ureteric bud branching morphogenesis that was produced by viral transduction with VVC-peGFP/PRKX.ca was also analyzed. Compared with the control kidneys that were injected with the empty lentiviral vector, constitutively active PRKX overexpression resulted in increased ureteric bud branching as determined by anticalbindin staining with confocal image analysis of the branched ureteric bud (Figure 6, A versus B) . Using IMAGE J software, we quantitatively analyzed numbers of ureteric bud branch tips and branch points, the first and second ureteric bud branch lengths, and ureteric bud branch diameters. Our results showed that PRKX expression significantly increased the number of ureteric branch tips and branch points compared with the control group (tips 34. Figure 6C ). PRKX expression also significantly increased the second ureteric branch lengths Figure 6D ). By contrast, the microinjection of kinase dead PRKX did not stimulate and tended to decrease parameters of ureteric bud development ( Figure 6 , E Figure 4 . Expression of pEGFP/PRKX in the cultured embryonic day 11 (E11) kidney. (A) VVC-peGFP/PRKX proviral stocks were titered on HeLa-TAT cells and delivered by microinjection into the lumen of the ureteric bud of E11 to E12 mouse metanephric kidneys. At these early stages of organogenesis, the ureteric bud lumen can be filled with nanoliter quantities of proviral supernatants, ensuring a high multiplicity of infection favoring high-efficiency transduction of the epithelial cell progenitors of the developing collecting duct system over the ensuing 3 to 5 d of organ culture. (B) A single epifluorescence image of an E11.5 mouse embryonic kidney after microinjection with the VVC-peGFP/PRKX.ca viral vector encoding a constitutively active PRKX kinase and 3 d of organ culture. Expression (GFP fluorescence) can be seen throughout the ureteric bud branching structure (compare with ureteric bud marker, calbindin, stained kidney in Figure 6E ). (C) A high-power image of the cells in the region of the VVC-peGFP/PRKX.ca microinjected ureteric bud denoted by the arrow in B shows green fluorescence in the cytoplasm of all cells and also in the nuclei of some cells at the outer surface of the bud tip (arrowheads). (D) E11 mouse embryonic kidney, microinjected with VVC (empty vector) alone and cultured for 3 d in organ culture, showed no detectable fluorescence by confocal microscopy.
versus F, and G). Similar trends to reduction in ureteric bud branching were seen in the presence of PRKX siRNA that reduced mRNA and protein levels by Ͼ70%. (data not shown).
Discussion
The PRKX kinase is a mammalian cAMP-dependent protein kinase that seems to have multiple functions in cellular differentiation and epithelial morphogenesis (26, 27) . Phylogenetic analysis based on sequence alignments of the core catalytic domains have shown that the human PRKX gene belongs to a unique and ancient family that includes Caenorhabditis elegans, Drosophila melanogaster, Dictyostelium discoideum, Ascaris suum, and Mus musculus PRKX homologous genes rather than to the classic PKA gene family (17) . The biologic function of the PRKX gene family member Dictyostelium kinase PKA-C has been studied intensively, and this kinase has been shown to play an essential role in the cell-shape changes and cell migration necessary for cell sorting during morphogenesis as well as in the transcriptional regulation of later cell fate differentiation during development (28 -31) . We therefore hypothesized that PRKX may play a role in the regulation of epithelial cell morphogenesis in the developing mammalian kidney. Studies by other laboratories had shown that PRKX was expressed in macrophages and granulocytes, and inhibition of PRKX expression blocked terminal differentiation in both the leukemic HL-60 cells and normal peripheral blood monocytes (19) . Our previous studies demonstrated that PRKX does activate renal epithelial cell migration and tubulogenesis in vitro (17) . Taken together, these results suggested that PRKX might have multiple roles in mammalian development, including tissue-specific cell differentiation in hematopoietic cells and epithelial cell morphogenesis in the developing kidney.
PRKX mRNA is expressed in the ureteric bud of fetal kidneys and the cyst epithelia of ADPKD kidneys but not in the normal adult kidney (17) . To explore further the distribution of PRKX mRNA in other fetal organs as well as its expression pattern in developing kidneys, we carried out high-stringency Northern blot analysis. Our results show that PRKX mRNA was also expressed in fetal heart, brain, lung, and skeletal muscle in addition to kidney, although very little expression was found in adult organs (and none in adult kidney) (15) . Northern blot analysis of PRKX mRNA in developing human fetal kidneys demonstrated expression from 12 to 24 wk gestational age, a gestational period when ureteric bud branching morphogenesis is highly active. Here, we further demonstrate that PRKX is expressed all of the way through the ureteric bud branching tubular structure from the inner stalk to the outer branching tips, suggesting a possible role in the direction and maintenance branching morphogenesis of the ureteric bud in the early phases of metanephric kidney development.
To determine whether PRKX can activate epithelial morphogenesis in the fetal kidney, we introduced a constitutively active form of PRKX into the ureteric bud lumen of E11 metanephric kidneys and analyzed its influence on development by organ culture. This was made possible by using high-titer VSVG pseudotyped lentiviral vectors. Use of this system allowed us to monitor the early growth and morphogenesis of kidneys continuously (3 to 7 d) after microinjection with PRKX lentiviral constructs. Whole-mount confocal microscopy demonstrated that the lentiviral vector-encoded PRKX was expressed throughout the entire ureteric bud-derived branched collecting system with cytoplasmic localization in all cells and nuclear localization in some cells at the extreme tips of the bud. Because this constitutively active mutant PRKX kinase is found predominantly in the nucleus Confocal image stacks of labeled kidneys were converted to Z projections. The Z projection from the green channel (anti-calbindin) was skeletonized using IMAGE J software to create a ureteric tree (A and B, right), which was used to determine the diameter and length of ureteric branches as well as to count the numbers of ureteric branch points and tips (C). The values are mean Ϯ SEM from six paired kidneys. *Significant difference between PRKX and control values (P Ͻ 0.005 for branch tips, P Ͻ 0.005 for branch points, and P Ͻ 0.05 for second ureteric branch lengths; D). (E) Paired E12 fetal kidneys that were microinjected with kinase dead VVC-pEGFP/PRKX-KD viral vector (E) or empty viral vector (F) stained with anti-calbindin. (G) Quantitative analysis of ureteric bud tips and points as in C shows no significant differences. of transfected LLC-PK1 renal epithelial cells, the largely cytoplasmic localization of this mutant PRKX kinase in most regions of the ureteric bud suggests that cAMP-independent mechanisms may regulate PRKX in vivo.
Intriguingly, this study shows that overexpression of constitutively active PRKX in the fetal kidney dramatically stimulates ureteric bud branching as well as promotes induction of increased numbers of glomeruli. The numbers of ureteric branch points and tips and the length of second branch segments all significantly increased in the kidneys that overexpressed constitutively active PRKX, compared with the paired control group kidneys that were microinjected with empty VVC vector alone. These studies identify a potential role for PRKX in renal development as a regulatory kinase controlling ureteric bud elongation and branching growth as well as nephron number. In this regard, our previous studies as well as studies of HFCT cells in vitro suggest that PRKX may have a moderately stimulatory effect on cell proliferation. The localization of PRKX mRNA in the inner deep portions of the ureteric bud branching stalk as well as throughout the structure to the outer branching tips shown by in situ hybridization (17) (Figure 2 ) suggest that PRKX may play an important role in directing branching morphogenesis at an early time in mammalian metanephric kidney development, when there is rapid growth of the collecting duct system.
To investigate whether the PRKX kinase affects the migration of tubular kidney epithelial cells, processes that are essential for the control of renal tubule branching morphogenesis, we conducted assays on HFCT epithelial cells that were transfected with PRKX. Our results showed that PRKX significantly increases HFCT cell migration in a modified Boyden chamber assay. These observations suggest that the activation of ureteric bud branching morphogenesis in the metanephric kidney by PRKX may be due at least in part to the activation of epithelial cell migration in the ureteric bud and its collecting duct derivatives.
The downstream phosphorylation targets of the PRKX kinase that mediate its effects on epithelial cell migration and branching morphogenesis have yet to be identified, although PRKX activity to phosphorylate the C-terminus of polycystin-1 (X.L., C.R.B., P.D.W., unpublished observations, 2004) suggests the C-terminus of polycystin-1 as one potential target. Focal adhesion complex proteins, including FAK, paxillin, c-src, p130cas, vinculin, talin, and ␣-actinin, play an important role in cell adhesion and migration, and phosphorylation of components of this complex is a key regulatory mechanism for these processes (32) (33) (34) . It is interesting that polycystin-1 has also been shown to form multiprotein complexes with proteins of the focal adhesion plaque, as well as with the cell-cell adherens protein complexes, and can also be found in apical collecting duct cilia (7) (8) (9) (10) . Recent studies have also suggested that polycystin-1 is likely involved in the regulation of epithelial tubulogenesis because expression of polycystin-1 can trigger branching morphogenesis of tubular kidney epithelial cells in vitro (35) , and overexpression of a 202-amino acid residue C-terminal polycystin-1 polypeptide disrupts branching morphogenesis in cultured mouse metanephric kidneys in organ culture (14) . Identification of the downstream targets of the PRKX kinase that mediate its effects on epithelial morphogenesis therefore may be important for elucidation of signaling pathways that normally regulate kidney organogenesis and are aberrantly activated in polycystic kidney diseases.
